A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients
Clinical trial NCT04041011 · COMPLETED
Trial details
- NCT number
- NCT04041011
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2021-04-23
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.